Legacy Financial Advisors, Inc. Pacira Bio Sciences, Inc. Transaction History

Legacy Financial Advisors, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 14, 2019	SELL	$36.47 - $42.17 $7,038 - $8,138	-193 Closed	0 $0
Q4 2018 Jan 16, 2019	SELL	$41.31 - $52.16 $1,363 - $1,721	-33 Reduced 14.6%	193 $8,000
Q2 2018 Jul 17, 2018	SELL	$27.5 - $39.8 $742 - $1,074	-27 Reduced 10.67%	226 $8,000
Q1 2018 Apr 12, 2018	BUY	$29.98 - $46.35 $1,558 - $2,410	52 Added 25.87%	253 $9,000
Q4 2017 Feb 09, 2018	BUY	$31.85 - $46.95 $6,401 - $9,436	201	201 $9,000

263

50.4M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Legacy Financial Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Legacy Financial Advisors, Inc. with notifications on news.